within Pharmacolibrary.Drugs.ATC.M;

model M01AC01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 1.3333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.014,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005833333333333334,
    Tlag           = 1800,            
    Vdp             = 0.012,
    k12             = 0.14,
    k21             = 0.14
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01AC01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class, used primarily for the symptomatic treatment of rheumatoid arthritis and osteoarthritis, as well as for musculoskeletal pain and inflammation. It is approved for use in many countries for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral dosing of piroxicam.</p><h4>References</h4><ol><li><p>Amidon, GL, et al., &amp; Crison, JR (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. <i>Pharmaceutical research</i> 12(3) 413–420. DOI:<a href=\"https://doi.org/10.1023/a:1016212804288\">10.1023/a:1016212804288</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7617530/\">https://pubmed.ncbi.nlm.nih.gov/7617530</a></p></li><li><p>Fleischmann, R, et al., &amp; Slobodin, G (2002). Meloxicam. <i>Expert opinion on pharmacotherapy</i> 3(10) 1501–1512. DOI:<a href=\"https://doi.org/10.1517/14656566.3.10.1501\">10.1517/14656566.3.10.1501</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12387696/\">https://pubmed.ncbi.nlm.nih.gov/12387696</a></p></li><li><p>Keiper, NL, et al., &amp; Hartup, BK (2017). PHARMACOKINETICS OF PIROXICAM IN CRANES (FAMILY GRUIDAE). <i>Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians</i> 48(3) 886–890. DOI:<a href=\"https://doi.org/10.1638/2016-0182.1\">10.1638/2016-0182.1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28920805/\">https://pubmed.ncbi.nlm.nih.gov/28920805</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01AC01;
